Kozhukhov Sergey, Dovganych Nataliia
SI "National Scientific Center "The M.D.Strazhesko Institute of Cardiology, ""Kyiv, Ukraine.
Front Cardiovasc Med. 2021 Aug 2;8:697240. doi: 10.3389/fcvm.2021.697240. eCollection 2021.
The collaboration of cardiologists, general practitioners (GPs), and oncologists is crucial in cancer patient management. We carried out a national-based survey-The Ukrainian National Survey (UkrNatSurv)-on behalf of the Cardio-Oncology (CO) Working Group (WG) of the Ukrainian Society of Cardiology to analyze the level of knowledge in cardio-oncology. A short questionnaire was presented to specialists involved in the management of cancer patients across the country. The questionnaire was made up of eight questions concerning referred cancer patient number, CV complications of cancer therapy, diagnostic methods to detect cardiotoxicity, and drugs used for its treatment. A total of 426 questionnaires of medical specialists from different regions of Ukraine were collected and analyzed; the majority of respondents were cardiologists (190), followed by GPs (177), 40 oncologists (mainly chemotherapists and hematologists), other -19 (imaging specialists, neurologists, endocrinologists, etc.). All responders were equally involved in the management of cancer patients. However, less than half of the patients have been seen before the start of cancer therapy. GPs observe the majority of patients after the end of treatment. All doctors are sufficiently aware of cancer therapy-associated CV complications. However, the necessary diagnostic tools, mostly biomarkers, are not used widely by different specialists. The criteria for cardiotoxicity, in particular, the level of reduction of the left ventricular ejection fraction (LVEF) as a marker of LV dysfunction, are not clearly understood. The specific knowledge in the management of CV complications in cancer is required. UkrNatSurv is the first survey in Ukraine to investigate the awareness of CO care provided to cancer patients with CV diseases (CVD) or developed CV complications. Providing such surveys among doctors involved in CO is an excellent tool to investigate the knowledge gaps in clinical practice. Therefore, the primary task is to develop a national educational CO program.
心脏病专家、全科医生(GP)和肿瘤学家之间的合作在癌症患者管理中至关重要。我们代表乌克兰心脏病学会心脏肿瘤学(CO)工作组开展了一项全国性调查——乌克兰全国调查(UkrNatSurv),以分析心脏肿瘤学方面的知识水平。向全国参与癌症患者管理的专家发放了一份简短问卷。该问卷由八个问题组成,涉及转诊的癌症患者数量、癌症治疗的心血管并发症、检测心脏毒性的诊断方法以及用于治疗的药物。共收集并分析了来自乌克兰不同地区的426份医学专家问卷;大多数受访者是心脏病专家(190人),其次是全科医生(177人),40名肿瘤学家(主要是化疗师和血液学家),其他19人(影像专家、神经学家、内分泌学家等)。所有受访者在癌症患者管理中参与程度相同。然而,不到一半的患者在癌症治疗开始前接受过检查。全科医生在治疗结束后观察大多数患者。所有医生都充分了解与癌症治疗相关的心血管并发症。然而,不同专家并未广泛使用必要的诊断工具,主要是生物标志物。对于心脏毒性的标准,特别是作为左心室功能障碍标志物的左心室射血分数(LVEF)降低水平,并未得到清晰理解。在癌症心血管并发症管理方面需要特定知识。UkrNatSurv是乌克兰首次调查为患有心血管疾病(CVD)或出现心血管并发症的癌症患者提供的心脏肿瘤学护理的认知情况。在参与心脏肿瘤学的医生中开展此类调查是调查临床实践中知识差距的绝佳工具。因此,首要任务是制定一项全国性的心脏肿瘤学教育计划。